Table 2.
Viral Load and CD4+ T-Cell Count Differences Between KIR Positives versus Negatives Under the Existence of Their Ligand HLA Alleles
| R square | B (95% CI) | β | P | |
| Viral load, log copies/mL | ||||
| HLA-C*02:02 + | 0.07 | |||
| KIR2DL1 + | −1.7 (−3.7 to 0.3) | −0.2 | .1 | |
| KIR2DS1 + | −0.6 (−1.3 to 0.08) | −0.2 | .08 | |
| HLA-C*16:01 + | 0.2 | |||
| KIR2DL2 + | 0.7 (−1.2 to 2.6) | 0.4 | .5 | |
| KIR2DL3 + | 1.6 (0.2 to 3.1) | 0.5 | .02 | |
| KIR2DS2 + | −0.3 (−2.2 to 1.6) | −0.1 | .8 | |
| CD4+ T cell, counts/mm3 | ||||
| HLA-C*16:01 + | 0.3 | |||
| KIR2DL2 + | −149 (−417 to 119) | −0.5 | .3 | |
| KIR2DL3 + | −276 (−473 to −78) | −0.5 | .008 | |
| KIR2DS2 + | 119 (−150 to 388) | 0.4 | .4 |
P values by multivariate linear regression model are shown.
Abbreviations: CI, confidence interval; HLA, human leukocyte antigen; KIR, killer immunoglobulin-like receptor.